MedPath

Evaluation of manualized neurofeedback training in outpatient psychosomatic psychotherapy treatment: a clinical pilot study.

Not Applicable
Conditions
Psychosomatic diseases, including affective disorders, somatoform disorders, post-traumatic stress disorders, adjustment disorders, as well as eating disorders
Registration Number
DRKS00031497
Lead Sponsor
VR-Universitätsklinik Essen, Klinik für Psychosomatische Medizin und Psychotherapie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
38
Inclusion Criteria

Presence of a psychosomatic diagnosis, written informed consent

Exclusion Criteria

Neurological diseases and diseases affecting the central nervous system, current conduction of high-frequency outpatient psychotherapy, lack of German language skills

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint will be theta band (4-8 Hz), alpha band (8-12 Hz), SMR band (12-15 Hz), and high-beta band (23-30 Hz) frequency bands measured at T0, T1, and T2 and during neurofeedback training sessions using electroencephalography. <br><br>T0 = Measurement before the start of neurofeedback training<br>T1 = measurement after 10 sessions of neurofeedback training<br>T2 = measurement 2 months after the last neurofeedback session
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints are <br>- muscle tension, blood volume pulse, respiratory rate measured during T0, T1 and T2<br>- Mood and subjective stress experience (measured using self-generated items) before and after each neurofeedback session<br>- Stress experience (measured with the PSQ), relaxation ability (measured with the RSQ), attention (derived from above EEG frequencies), self-efficacy (measured with the SWE), quality of life (measured with the WHOQOL-Bref), depressive symptoms (measured with the PHQ-8), anxious symptoms (measured with the GAD-7), insomnia (measured with the ISI) at T0, T1, and T2<br>- Acceptability and feasibility (measured using self-generated items), satisfaction (measured using the ZUF-8), and usefulness (measured using the SUS) at T1<br><br>In addition, employees (neurofeedback users) of the Clinic for Psychosomatic Medicine and Psychotherapy will be surveyed about the acceptance and feasibility of the neurofeedback offer during the course of the study.
© Copyright 2025. All Rights Reserved by MedPath